Up-regulation of PD-1 expression on NK cells has been reported in patients with ovarian carcinoma [82], Kaposi sarcoma [83], renal cell carcinoma [84], Hodgkin lymphoma [85], and multiple myeloma [86] as well as a number of digestive cancers [87]. This evidence concerns the gene PDCD1 and plasma cell myeloma.